American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$416M |
| 2 |
PepsiCo
PEP
|
+$370M |
| 3 |
Aptiv
APTV
|
+$289M |
| 4 |
Johnson & Johnson
JNJ
|
+$283M |
| 5 |
NXP Semiconductors
NXPI
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$339M |
| 2 |
INXN
Interxion Holding N.V.
INXN
|
+$320M |
| 3 |
Apple
AAPL
|
+$239M |
| 4 |
Booz Allen Hamilton
BAH
|
+$236M |
| 5 |
Roper Technologies
ROP
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Financials | 16.35% |
| 3 | Healthcare | 15.09% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGTI
701
DELISTED
PGT, Inc.
PGTI
| $9.43M | 0.01% |
632,246
+144,999
| +30% | +$2.31M |
|
702
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
| $9.4M | 0.01% |
292,027
+254,181
| +672% | +$7.54M |
|
703
Casella Waste Systems
CWST
$5.76B
| $9.35M | 0.01% |
203,183
+58,183
| +40% | +$2.57M |
|
|
UFS
704
DELISTED
DOMTAR CORPORATION (New)
UFS
| $9.3M | 0.01% |
243,175
-404,452
| -62% | -$15M |
|
705
Alamos Gold
AGI
$14B
| $9.15M | 0.01% |
1,519,798
-278,902
| -16% | -$1.52M |
|
706
VanEck High Yield Muni ETF
HYD
$4.4B
| $8.98M | 0.01% |
+140,200
| New | +$9M |
|
707
Best Buy
BBY
$17.5B
| $8.96M | 0.01% |
102,076
+87,919
| +621% | +$6.73M |
|
708
Clorox
CLX
$12.8B
| $8.96M | 0.01% |
+58,356
| New | +$8.72M |
|
709
PTC Therapeutics
PTCT
$6.06B
| $8.95M | 0.01% |
186,375
+76,061
| +69% | +$3.23M |
|
710
Pan American Silver
PAAS
$22.1B
| $8.95M | 0.01% |
377,622
-152,478
| -29% | -$2.82M |
|
711
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $8.88M | 0.01% |
27,604
+14,904
| +117% | +$4.59M |
|
712
Advanced Energy
AEIS
$13.5B
| $8.88M | 0.01% |
124,737
+16,478
| +15% | +$1.03M |
|
|
EPAY
713
DELISTED
Bottomline Technologies Inc
EPAY
| $8.86M | 0.01% |
165,228
+63,459
| +62% | +$2.89M |
|
|
AZUL
714
DELISTED
Azul
AZUL
| $8.67M | 0.01% |
202,672
-122,623
| -38% | -$4.72M |
|
715
Inspire Medical Systems
INSP
$1.68B
| $8.66M | 0.01% |
116,714
+53,754
| +85% | +$3.46M |
|
|
GRMN
716
Garmin
GRMN
$59.8B
| $8.62M | 0.01% |
88,374
-140,776
| -61% | -$13.1M |
|
|
MDRX
717
DELISTED
Veradigm Inc. Common Stock
MDRX
| $8.62M | 0.01% |
878,262
-419,515
| -32% | -$4.42M |
|
718
Acadia Healthcare
ACHC
$2.95B
| $8.61M | 0.01% |
259,233
+75,231
| +41% | +$2.36M |
|
719
Insulet
PODD
$10.1B
| $8.56M | 0.01% |
50,024
-196,101
| -80% | -$32.7M |
|
720
Fortinet
FTNT
$118B
| $8.54M | 0.01% |
400,005
+364,645
| +1,031% | +$6.86M |
|
|
AVLR
721
DELISTED
Avalara, Inc.
AVLR
| $8.54M | 0.01% |
116,517
-12,065
| -9% | -$876K |
|
|
GBT
722
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $8.43M | 0.01% |
106,033
+40,715
| +62% | +$2.41M |
|
|
NVMI
723
Nova
NVMI
$12.9B
| $8.35M | 0.01% |
220,671
+137,727
| +166% | +$4.83M |
|
|
AUY
724
DELISTED
Yamana Gold, Inc.
AUY
| $8.26M | 0.01% |
2,091,480
-390,397
| -16% | -$1.37M |
|
725
Iovance Biotherapeutics
IOVA
$3.05B
| $8.25M | 0.01% |
298,044
+103,500
| +53% | +$2.35M |
|
Similar funds
American Century Companies's Q4 2019 Portfolio in Review
As of Q4 2019, American Century Companies held 1,608 positions worth $105B, up 5.4% from $99.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
American Century Companies's Q4 2019 filing shows 405 new, 473 increased, 604 reduced and 116 closed positions. Its largest new stake was NXP Semiconductors: 2,360,390 shares worth $300M. The largest sale was iShares Russell 1000 Value ETF, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2019 buy was NXP Semiconductors: 2,360,390 shares worth $300M.
- American Century Companies added most to Texas Instruments in Q4 2019, an estimated $416M increase.
- American Century Companies's biggest Q4 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $339M.
- American Century Companies fully exited Celgene Corp in Q4 2019, selling an estimated $127M.
- American Century Companies's ten largest holdings make up 19% of its $105B portfolio in Q4 2019.
- American Century Companies opened 405 new positions and closed 116 in Q4 2019.
- American Century Companies's portfolio value rose 5.4% quarter-over-quarter to $105B.
Based on American Century Companies's 13F filing for Q4 2019, filed 12 Feb 2020.